Skip to content
Home » News » Communique – Feb. 20, 2001

Communique – Feb. 20, 2001

special edition

action alert

MORNING-AFTER ABORTION PILL: On February 14, a coalition of 60 pro-abortion groups filed a petition with the FDA, asking that morning-after abortion pills be made available over the counter. The FDA has 180 days to respond to the petition.

In addition, the maker of one abortifacient morning-after pill has launched a series of clinical trials in an effort to convince the FDA to let pharmacists dispense the drug without a doctor’s prescription.

Therefore, pro-life groups and individuals are being urged to write the FDA and comment. The message is a simple one: Don’t do it! In fact, the FDA should be told to withdraw the pills because they do not prevent abortion; they ARE abortion.

CONTACT: Dockets Management Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD 20852. You can also e-mail the FDA at .

(Reading: “Emergency Contraception Safer than Aspirin,” Center for Reproductive Law and Policy news release, 2/14/01; “Tests to Begin for Over-the-counter Sales of Morning-after Pill,” Catholic World News, 2/14/01; for complete information on the abortifacient nature of this chemical, see “Morning After Pill“)